• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

光敏剂化合物对严重急性呼吸综合征冠状病毒2的强效抑制作用

Potent inhibition of Severe Acute Respiratory Syndrome Coronavirus 2 by photosensitizers compounds.

作者信息

Yu Shujuan, Sun Gaohui, Sui Yaqun, Li Hanlin, Mai Yuhan, Wang Guodong, Zhang Ning, Bi Yuhai, Gao George F, Xu Peng, Jiang Longguang, Yuan Cai, Yang Yang, Huang Mingdong

机构信息

College of Chemistry, Fuzhou University, Fujian, 350108, China.

CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Center for Influenza Research and Early-warning (CASCIRE), CAS-TWAS Center of Excellence for Emerging Infectious Diseases (CEEID), Chinese Academy of Sciences, Beijing, 100101, China.

出版信息

Dyes Pigm. 2021 Oct;194:109570. doi: 10.1016/j.dyepig.2021.109570. Epub 2021 Jun 22.

DOI:10.1016/j.dyepig.2021.109570
PMID:34183871
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8216852/
Abstract

The ongoing pandemic of coronavirus disease 2019 (COVID-19) posed a major challenge to the public health. Currently, no proven antiviral treatment for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection is available. Here we report compounds pentalysine β-carbonylphthalocyanine zinc (ZnPc5K) and chlorin e6 (ce6) potently inhibited the viral infection and replication in vitro with EC values at nanomolar level. These compounds were first identified by screening a panel of photosensitizers for photodynamic viral inactivation. Such viral inactivation strategy is implementable, and has unique advantages, including resistance to virus mutations, affordability compared to the monoclonal antibodies, and lack of long-term toxicity.

摘要

2019年冠状病毒病(COVID-19)的持续流行对公共卫生构成了重大挑战。目前,尚无经证实的针对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染的抗病毒治疗方法。在此,我们报告化合物五赖氨酸β-羰基酞菁锌(ZnPc5K)和二氢卟吩e6(ce6)在体外能有效抑制病毒感染和复制,其半数有效浓度(EC)值处于纳摩尔水平。这些化合物最初是通过筛选一组用于光动力病毒灭活的光敏剂而鉴定出来的。这种病毒灭活策略是可行的,并且具有独特的优势,包括对病毒突变具有抗性、与单克隆抗体相比价格可承受,以及无长期毒性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f705/8216852/dc9374c4b809/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f705/8216852/f3dbe7ebc191/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f705/8216852/dc9374c4b809/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f705/8216852/f3dbe7ebc191/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f705/8216852/dc9374c4b809/gr2_lrg.jpg

相似文献

1
Potent inhibition of Severe Acute Respiratory Syndrome Coronavirus 2 by photosensitizers compounds.光敏剂化合物对严重急性呼吸综合征冠状病毒2的强效抑制作用
Dyes Pigm. 2021 Oct;194:109570. doi: 10.1016/j.dyepig.2021.109570. Epub 2021 Jun 22.
2
Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease.冠状病毒对抗病毒药物瑞德西韦(GS-5734)的易感性是由病毒聚合酶和校对核糖核酸外切酶介导的。
mBio. 2018 Mar 6;9(2):e00221-18. doi: 10.1128/mBio.00221-18.
3
Replication of Severe Acute Respiratory Syndrome Coronavirus 2 in Human Respiratory Epithelium.严重急性呼吸综合征冠状病毒 2 在人呼吸道上皮细胞中的复制。
J Virol. 2020 Jul 16;94(15). doi: 10.1128/JVI.00957-20.
4
Perilla (Perilla frutescens) leaf extract inhibits SARS-CoV-2 via direct virus inactivation.紫苏(Perilla frutescens)叶提取物通过直接病毒失活抑制 SARS-CoV-2。
Biomed J. 2021 Jun;44(3):293-303. doi: 10.1016/j.bj.2021.01.005. Epub 2021 Jan 28.
5
Novel Photosensitizer β-Mannose-Conjugated Chlorin e6 as a Potent Anticancer Agent for Human Glioblastoma U251 Cells.新型光敏剂β-甘露糖共轭二氢卟吩e6作为人胶质母细胞瘤U251细胞的强效抗癌剂
Pharmaceuticals (Basel). 2020 Oct 16;13(10):316. doi: 10.3390/ph13100316.
6
The rocaglate CR-31-B (-) inhibits SARS-CoV-2 replication at non-cytotoxic, low nanomolar concentrations in vitro and ex vivo.罗卡胍 CR-31-B(-)在体外和离体条件下以非细胞毒性、低纳摩尔浓度抑制 SARS-CoV-2 复制。
Antiviral Res. 2021 Feb;186:105012. doi: 10.1016/j.antiviral.2021.105012. Epub 2021 Jan 8.
7
Antiviral Activity of the Propylamylatin Formula against the Novel Coronavirus SARS-CoV-2 In Vitro Using Direct Injection and Gas Assays in Virus Suspensions.采用直接注射和气体检测法在病毒悬浮液中评估丙戊酰拉亭配方对新型冠状病毒 SARS-CoV-2 的抗病毒活性
Viruses. 2021 Mar 5;13(3):415. doi: 10.3390/v13030415.
8
Remdesivir against COVID-19 and Other Viral Diseases.瑞德西韦治疗 COVID-19 及其他病毒性疾病。
Clin Microbiol Rev. 2020 Oct 14;34(1). doi: 10.1128/CMR.00162-20. Print 2020 Dec 16.
9
Some natural compounds and their analogues having potent anti- SARS-CoV-2 and anti-proteases activities as lead molecules in drug discovery for COVID-19.一些具有强大的抗SARS-CoV-2和抗蛋白酶活性的天然化合物及其类似物,可作为COVID-19药物研发中的先导分子。
Eur J Med Chem Rep. 2022 Dec;6:100079. doi: 10.1016/j.ejmcr.2022.100079. Epub 2022 Aug 28.
10
Rescue of SARS-CoV-2 from a Single Bacterial Artificial Chromosome.从单个细菌人工染色体中拯救 SARS-CoV-2。
mBio. 2020 Sep 25;11(5):e02168-20. doi: 10.1128/mBio.02168-20.

引用本文的文献

1
Recent Progress of Organic-Inorganic Hybrid Perovskites in RRAM, Artificial Synapse, and Logic Operation.有机-无机杂化钙钛矿在电阻式随机存取存储器、人工突触和逻辑运算中的最新进展
Small Sci. 2021 Nov 10;2(2):2100086. doi: 10.1002/smsc.202100086. eCollection 2022 Feb.
2
A deep-red fluorophore based on naphthothiadiazole as emitter with hybridized local and charge transfer and ambipolar transporting properties for electroluminescent devices.一种基于萘并噻二唑作为发光体的深红色荧光团,具有杂化的局域和电荷转移以及双极性传输特性,用于电致发光器件。
Beilstein J Org Chem. 2023 Nov 3;19:1664-1676. doi: 10.3762/bjoc.19.122. eCollection 2023.
3

本文引用的文献

1
Robust SARS-CoV-2 infection in nasal turbinates after treatment with systemic neutralizing antibodies.经系统中和抗体治疗后,鼻甲骨中出现稳健的 SARS-CoV-2 感染。
Cell Host Microbe. 2021 Apr 14;29(4):551-563.e5. doi: 10.1016/j.chom.2021.02.019. Epub 2021 Feb 25.
2
A novel virtual screening procedure identifies Pralatrexate as inhibitor of SARS-CoV-2 RdRp and it reduces viral replication in vitro.一种新的虚拟筛选程序将普拉曲沙鉴定为 SARS-CoV-2 RdRp 的抑制剂,并在体外降低病毒复制。
PLoS Comput Biol. 2020 Dec 31;16(12):e1008489. doi: 10.1371/journal.pcbi.1008489. eCollection 2020 Dec.
3
Spike mutation D614G alters SARS-CoV-2 fitness.
Membrane-Targeting Perylenylethynylphenols Inactivate Medically Important Coronaviruses via the Singlet Oxygen Photogeneration Mechanism.
膜靶向苝二炔基酚类化合物通过单线态氧光生成机制使具有医学重要性的冠状病毒失活。
Molecules. 2023 Aug 28;28(17):6278. doi: 10.3390/molecules28176278.
4
Targeted photodynamic neutralization of SARS-CoV-2 mediated by singlet oxygen.靶向单重态氧介导的 SARS-CoV-2 光动力中和
Photochem Photobiol Sci. 2023 Jun;22(6):1323-1340. doi: 10.1007/s43630-023-00381-w. Epub 2023 Feb 8.
5
Near-Infrared Dyes: Towards Broad-Spectrum Antivirals.近红外染料:广谱抗病毒药物的发展。
Int J Mol Sci. 2022 Dec 22;24(1):188. doi: 10.3390/ijms24010188.
6
A new class of quaternary ammonium compounds as potent and environmental friendly disinfectants.一类新型的季铵化合物,作为高效且环保的消毒剂。
J Clean Prod. 2022 Dec 15;379:134632. doi: 10.1016/j.jclepro.2022.134632. Epub 2022 Oct 11.
7
Punicalagin as an allosteric NSP13 helicase inhibitor potently suppresses SARS-CoV-2 replication in vitro.鞣花酸作为一种别构 NSP13 解旋酶抑制剂,能够在体外有效抑制 SARS-CoV-2 的复制。
Antiviral Res. 2022 Oct;206:105389. doi: 10.1016/j.antiviral.2022.105389. Epub 2022 Aug 17.
8
Photodynamic Inactivation of SARS-CoV-2 Infectivity and Antiviral Treatment Effects In Vitro.光动力灭活 SARS-CoV-2 感染性和抗病毒治疗效果的体外研究。
Viruses. 2022 Jun 14;14(6):1301. doi: 10.3390/v14061301.
9
Photodynamic Inactivation of Human Coronaviruses.光动力灭活人冠状病毒。
Viruses. 2022 Jan 8;14(1):110. doi: 10.3390/v14010110.
刺突突变 D614G 改变了 SARS-CoV-2 的适应性。
Nature. 2021 Apr;592(7852):116-121. doi: 10.1038/s41586-020-2895-3. Epub 2020 Oct 26.
4
Methylene blue inhibits replication of SARS-CoV-2 in vitro.亚甲蓝在体外抑制 SARS-CoV-2 的复制。
Int J Antimicrob Agents. 2020 Dec;56(6):106202. doi: 10.1016/j.ijantimicag.2020.106202. Epub 2020 Oct 16.
5
A phase Ι study to evaluate the application of photocyanine using pharmacokinetic and pharmacodynamic analysis in patients with malignancy.一项评估光氰在恶性肿瘤患者中应用的Ⅰ期研究,采用药代动力学和药效学分析。
Cancer Chemother Pharmacol. 2020 Aug;86(2):267-276. doi: 10.1007/s00280-020-04096-y. Epub 2020 Jul 24.
6
Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review.新型冠状病毒病 2019(COVID-19)的病理生理学、传播、诊断和治疗:综述。
JAMA. 2020 Aug 25;324(8):782-793. doi: 10.1001/jama.2020.12839.
7
COVID-19: Beyond the virus. The use of photodynamic therapy for the treatment of infections in the respiratory tract.新型冠状病毒肺炎:病毒之外。光动力疗法在呼吸道感染治疗中的应用。
Photodiagnosis Photodyn Ther. 2020 Sep;31:101804. doi: 10.1016/j.pdpdt.2020.101804. Epub 2020 May 8.
8
The Time Sequences of Respiratory and Rectal Viral Shedding in Patients With Coronavirus Disease 2019.2019冠状病毒病患者呼吸道和直肠病毒脱落的时间序列
Gastroenterology. 2020 Sep;159(3):1158-1160.e2. doi: 10.1053/j.gastro.2020.05.035. Epub 2020 May 16.
9
SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)进入因子与固有免疫基因一起在鼻上皮细胞中高表达。
Nat Med. 2020 May;26(5):681-687. doi: 10.1038/s41591-020-0868-6. Epub 2020 Apr 23.
10
Photodynamic antimicrobial chemotherapy using zinc phthalocyanine derivatives in treatment of bacterial skin infection.使用酞菁锌衍生物的光动力抗菌化疗治疗细菌性皮肤感染。
J Biomed Opt. 2016 Jan;21(1):18001. doi: 10.1117/1.JBO.21.1.018001.